1. Gao, L, Nie, X, Zhang, W, et al. Identification of long noncoding RNA RP11-89K21.1 and RP11-357H14.17 as prognostic signature of endometrial carcinoma via integrated bioinformatics analysis. Cancer Cell Int. 2020;20:268.
Google Scholar | Crossref | Medline2. Morice, P, Leary, A, Creutzberg, C, Abu-Rustum, N, Darai, E. Endometrial cancer. Lancet (London, England). 2016;387(10023):1094-1108.
Google Scholar | Crossref | Medline3. Goad, J, Ko, YA, Kumar, M, Jamaluddin, MFB, Tanwar, PS. Oestrogen fuels the growth of endometrial hyperplastic lesions initiated by overactive Wnt/β-catenin signalling. Carcinogenesis. 2018;39(9):1105-1116.
Google Scholar | Crossref | Medline4. Xu, X, Zheng, S. MiR-887-3p negatively regulates STARD13 and promotes pancreatic cancer progression. Cancer Manag Res. 2020;12:6137-6147.
Google Scholar | Crossref | Medline5. Zhang, W, Ji, W, Li, T, Liu, T, Zhao, X. MiR-145 functions as a tumor suppressor in papillary thyroid cancer by inhibiting RAB5C. Int J Med Sci. 2020;17(13):1992-2001.
Google Scholar | Crossref | Medline6. Liu, CH, Jing, XN, Liu, XL, Qin, SY, Liu, MW, Hou, CH. Tumor-suppressor miRNA-27b-5p regulates the growth and metastatic behaviors of ovarian carcinoma cells by targeting CXCL1. J Ovarian Res. 2020;13(1):92.
Google Scholar | Crossref | Medline7. Zhang, L, Ma, C, Wang, X, et al. MicroRNA-874-5p regulates autophagy and proliferation in pulmonary artery smooth muscle cells by targeting sirtuin 3. Eur J Pharmacol. 2020;888:173485.
Google Scholar | Crossref | Medline8. Correia de Sousa, M, Gjorgjieva, M, Dolicka, D, Sobolewski, C, Foti, M. Deciphering miRNAs' action through miRNA editing. Int J Mol Sci. 2019;20(24):6249.
Google Scholar | Crossref | Medline9. Tiwari, A, Mukherjee, B, Dixit, M. MicroRNA Key to angiogenesis regulation: miRNA biology and therapy. Curr Cancer Drug Targets. 2018;18(3):266-277.
Google Scholar | Crossref | Medline10. Fabian, MR, Sonenberg, N. The mechanics of miRNA-mediated gene silencing: a look under the hood of miRISC. Nat Struct Mol Biol. 2012;19(6):586-593.
Google Scholar | Crossref | Medline11. Zheng, X, Xu, K, Zhu, L, Mao, M, Zhang, F, Cui, L. MiR-486-5p Act as a biomarker in endometrial carcinoma: promotes cell proliferation, migration, invasion by targeting MARK1. Onco Targets Ther. 2020;13:4843-4853.
Google Scholar | Crossref | Medline12. Zhang, HH, Li, R, Li, YJ, et al. eIF4E-related miR-320a and miR-340-5p inhibit endometrial carcinoma cell metastatic capability by preventing TGF-β1-induced epithelial-mesenchymal transition. Oncol Rep. 2020;43(2):447-460.
Google Scholar | Medline13. Du, J, Zhang, F, Zhang, L, Jia, Y, Chen, H. MicroRNA-103 regulates the progression in endometrial carcinoma through ZO-1. Int J Immunopathol Pharmacol. 2019;33:1-8.
Google Scholar | SAGE Journals14. Cai, X, Qu, L, Yang, J, et al. Exosome-transmitted microRNA-133b inhibited bladder cancer proliferation by upregulating dual-specificity protein phosphatase 1. Cancer Med. 2020;9(16):6009-6019.
Google Scholar | Crossref | Medline15. Xu, Y, Ma, Y, Liu, XL, Gao, SL. Mir-133b affects cell proliferation, invasion and chemosensitivity in renal cell carcinoma by inhibiting the ERK signaling pathway. Mol Med Rep. 2020;22(1):67-76.
Google Scholar | Crossref | Medline16. Chen, GY, Ruan, L. Downregulation Of microRNA-133b And Its clinical value In Non-small cell lung cancer. Onco Targets Ther. 2019;12:9421-9434.
Google Scholar | Crossref | Medline17. Sanyal, S, Mondal, P, Sen, S, Sengupta Bandyopadhyay, S, Das, C. SUMO E3 ligase CBX4 regulates hTERT-mediated transcription of CDH1 and promotes breast cancer cell migration and invasion. Biochem J. 2020;477(19):3803-3818.
Google Scholar | Crossref | Medline18. Katayama, A, Ogino, T, Bandoh, N, et al. Overexpression of small ubiquitin-related modifier-1 and sumoylated Mdm2 in oral squamous cell carcinoma: possible involvement in tumor proliferation and prognosis. Int J Oncol. 2007;31(3):517-524.
Google Scholar | Medline19. Xu, H, Wang, H, Zhao, W, et al. SUMO1 Modification of methyltransferase-like 3 promotes tumor progression via regulating snail mRNA homeostasis in hepatocellular carcinoma. Theranostics. 2020;10(13):5671-5686.
Google Scholar | Crossref | Medline20. Zhang, A, Tao, W, Zhai, K, et al. Protein sumoylation with SUMO1 promoted by Pin1 in glioma stem cells augments glioblastoma malignancy. Neuro Oncol. 2020;22(12):1809-1821.
Google Scholar | Crossref | Medline21. Clough, E, Barrett, T. The gene expression omnibus database. Methods In Molecular Biology (Clifton, NJ). 2016;1418:93-110.
Google Scholar | Crossref | Medline22. Martin, B, Chadwick, W, Yi, T, et al. VENNTURE--a novel venn diagram investigational tool for multiple pharmacological dataset analysis. PloS One. 2012;7(5):e36911.
Google Scholar | Crossref | Medline23. Hou, GX, Liu, P, Yang, J, Wen, S. Mining expression and prognosis of topoisomerase isoforms in non-small-cell lung cancer by using oncomine and Kaplan-Meier plotter. PloS One. 2017;12(3):e0174515.
Google Scholar | Crossref | Medline24. Deng, JL, Xu, YH, Wang, G. Identification of potential crucial genes and Key pathways in breast cancer using bioinformatic analysis. Front Genet. 2019;10:695.
Google Scholar | Crossref | Medline25. Zhang, K, Zhou, H, Yan, B, Cao, X. TUG1/miR-133b/CXCR4 Axis regulates cisplatin resistance in human tongue squamous cell carcinoma. Cancer Cell Int. 2020;20:148.
Google Scholar | Crossref | Medline26. Kowalewska, M, Bakula-Zalewska, E, Chechlinska, M, et al. microRNAs in uterine sarcomas and mixed epithelial-mesenchymal uterine tumors: a preliminary report. Tumour Biology : The Journal of the International Society for Oncodevelopmental Biology and Medicine. 2013;34(4):2153-2160.
Google Scholar | Crossref | Medline27. Chen, SW, Wang, TB, Tian, YH, Zheng, YG. Down-regulation of microRNA-126 and microRNA-133b acts as novel predictor biomarkers in progression and metastasis of non small cell lung cancer. Int J Clin Exp Pathol. 2015;8(11):14983-14988.
Google Scholar | Medline28. Zhao, N, Liu, H, Zhang, A, Wang, M. Expression levels and clinical significance of miR-203 and miR-133b in laryngeal carcinoma. Oncol Lett. 2020;20(5):213.
Google Scholar | Crossref | Medline29. Yuan, H, Deng, R, Zhao, X, et al. SUMO1 Modification of KHSRP regulates tumorigenesis by preventing the TL-G-rich miRNA biogenesis. Mol Cancer. 2017;16(1):157.
Google Scholar | Crossref | Medline30. Liu, K, Wang, X, Li, D, et al. Ginkgolic acid, a SUMO-1 inhibitor, inhibits the progression of oral squamous cell carcinoma by alleviating SUMOylation of SMAD4. Mol Ther Oncolytics. 2020;16:86-99.
Google Scholar | Crossref | Medline31. Ke, J, Yang, Y, Che, Q, et al. Prostaglandin E2 (PGE2) promotes proliferation and invasion by enhancing SUMO-1 activity via EP4 receptor in endometrial cancer. Tumour Biology : The Journal of the International Society for Oncodevelopmental Biology and Medicine. 2016;37(9):12203-12211.
Google Scholar | Crossref | Medline32. Zheng, J, Liu, L, Wang, S, Huang, X. SUMO-1 Promotes ishikawa cell proliferation and apoptosis in endometrial cancer by increasing sumoylation of histone H4. International Journal Of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society. 2015;25(8):1364-1368.
Google Scholar | Crossref | Medline33. Yuan, L, Jiang, ZM, Chen, XH, et al. [Hypoxia inducible factor-1α deSUMOylation reduces the stemness maintenance ability of endometrial cancer stem cell and increases its chemosensitivity]. Zhonghua yi xue za zhi. 2017;97(45):3579-3582.
Google Scholar | Medline34. Li, J, Sun, H, Liu, T, Kong, J. MicroRNA-423 promotes proliferation, migration and invasion and induces chemoresistance of endometrial cancer cells. Exp Ther Med. 2018;16(5):4213-4224.
Google Scholar | Medline35. Cui, Y, Wu, F, Tian, D, et al. miR-199a-3p enhances cisplatin sensitivity of ovarian cancer cells by targeting ITGB8. Oncol Rep. 2018;39(4):1649-1657.
Google Scholar | Medline